Continuation of medical devices: product id 977a275, serial# (b)(4),implanted: (b)(6) 2017, explanted: (b)(6) 2017, product type lead.Product id 977a275, serial# (b)(4) implanted: (b)(6) 2017, explanted: (b)(6) 2017, product type lead.Information references the main component of the system.Other relevant device(s) are: product id: 977a275, serial/lot #: (b)(4), ubd: 13-jun-2019, udi#: (b)(4); product id: 977a275, serial/lot #: (b)(4), ubd: 08-apr-2019, udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
|
Information was received from a healthcare professional of a clinical study regarding a patient with an implantable neurostimulator (ins) for spinal pain.It was reported that the patient experienced painful and tenderness over the surgical scar in the left gluteal ins pocket.The device was repositioned multiple times due to patient having discomfort over the ins site.There was a suspected abscess in the left gluteal ins pocket/left buttock region where the ins was lastly located.The event resulted in an unscheduled clinic or office visit, er visit, and in-patient hospitalization.On (b)(6) 2017 a surgical revision of the scar was performed; resection of the subcutaneous scar tissue.A sample was taken to bacteriology, which was positive for infection.Culture was positive for growth of coagulase, but (b)(6) for (b)(6).On (b)(6) 2017 the patient reported pain and discomfort.Fluid accumulation was found around all components of the spinal cord stimulation system.It was decided to completely remove the ins and two spinal cord stimulation electrodes.The event was not related to the device or therapy, but related to the implant procedure.The outcome was resolved without sequelae on (b)(6) 2017.No further complications were reported or anticipated.
|